Skip to content

Are You Passionate About Advancing the Future of Cell Therapies?

Make an Impact

Led by some of the most respected experts in the biotechnology field, we are leading the development of advanced iPSC-derived cell-based immunotherapies for oncological and regenerative medicine applications. Our founding team is known for their domain expertise and industry experience. We work from a well-defined strategy using the most advanced platform technologies. This has given rise to our exclusive differentiation methods and genetic reprogramming, which we believe surpasses what’s currently being done in cell therapies.

We strive to create an industry leading culture to maximize the potential of our diverse team

Our core values that govern everything we do
TEAMWORK

by collaborating together we can achieve exceptional results

PASSION

we are passionate about helping critically ill patients

INNOVATION

we strive to push the assumed boundaries in all aspects of our business

OPTIMISM

we face every challenge with optimism

INTEGRITY

we speak the truth and conduct business in an honorable way

BELONGING

we are committed to diversity and embrace different perspectives and ideas, creating belonging for all

Do You Share Our Vision?

Our vision is to create safe, effective, and affordable immunotherapies for the treatment of seriously ill patients.

To achieve this end, we foster an environment that pushes the boundaries of scientific innovation, and creates a culture that values integrity, teamwork, tenacity, and transparency.

More than just Talent

We are looking for committed, passionate and hard-working individuals that share our vision of advancing the domain of cell therapies. We embrace a mindset that is open to learning new things, sharing knowledge, and willing to do what it takes to reach our collective commitments.

Become a part of our
talented, results-driven team!

Come and Join Us!

We are actively hiring top-tier talent to be instrumental in helping us expand our expertise in iPSC differentiation methods and genetic reprogramming and to advance our pipeline of cell therapies.

Be Instrumental in Building the Future of Cell Therapies